Australian Genomics Of Chronic Allograft Dysfunction Study

Recruiting now

Conditions studied: Kidney Transplant Rejection, Kidney Transplant; Complications

In brief

The goal of the Australian Genomics of Chronic Allograft Dysfunction (AUSCAD) study is a single centre (Westmead Hospital), prospective, observational study, which enrols patients at time of kidney (or kidney-transplant) transplant and tracks the post transplant course. The AUSCAD study aims to generate new knowledge and improve outcomes following kidney transplantation. The primary aim is to determine whether important outcomes (including chronic rejection and graft loss) are correlated with patterns of allograft reactivity, gene expression and susceptibility profiles.

Key facts

Study ID
NCT06314230
Run by
Western Sydney Local Health District
People needed
500
Starts
2012-04-26
Expected to finish
2040-01-01
Last updated by the study team
2025-07-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.